{
  "id": 10935471,
  "title": "Rafael Reports Phase 3 Trappsol Cyclo Data In NPC",
  "url": "https://urgent.news/2026/09/30/rafael-reports-phase-3-trappsol-cyclo-data-in-npc",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-30T11:41:20.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/rafael-reports-phase-3-trappsol-cyclo-data-npc"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Wednesday, Rafael Holdings (RFL) reported topline results from the pivotal Phase 3 TransportNPC study evaluating Trappsol Cyclo in patients with Niemann-Pick Disease Type C (NPC).",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}